secwatch.observer — SEC 8-K summary
======================================

Issuer:     ADIAL PHARMACEUTICALS, INC. (ADIL)
CIK:        0001513525
Form:       8-K
Filed at:   2025-05-15T23:59:59+00:00
Accession:  0001213900-25-043733
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.08, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Adial Pharmaceuticals sets 2025 Annual Meeting for July 24; proposal deadlines revised
--------------------------------------------------------------------------------

- Annual meeting scheduled for July 24, 2025; record date June 4, 2025.
- Rule 14a-8 stockholder proposal deadline: May 25, 2025.
- Director nominations and non-14a-8 proposals due by May 25, 2025.
- Universal proxy rule compliance notice also due May 25, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1513525/000121390025043733/0001213900-25-043733-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1513525/000121390025043733/ea0242287-8k_adial.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-043733

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer